Tim Q. Duong, Ph.D., is a Professor at Albert Einstein College of Medicine, affiliated with the Departments of Radiology, Biochemistry, Ophthalmology & Visual Sciences, and Neuroscience. His research focuses on medical imaging, MRI, image analysis, machine learning, and predictive modeling for studying diseases like COVID-19 , neurodegeneration (Alzheimer's, multiple sclerosis), brain injuries , and breast cancer . Develops AI-driven MRI techniques for early disease detection Investigates neuroplasticity in glaucoma and diabetic retinopathy Leads grants from NIH and National Eye Institute Research Trends : Recent publications emphasize AI integration in medical imaging, long-term effects of SARS-CoV-2, and advanced MRI applications for ocular and neurological disorders. Grants include multiple R01 awards for diabetic retinopathy and glaucoma studies. Training Opportunities : Actively recruits postdocs, research coordinators, and faculty. Offers research positions for graduate, medical, and high school students, including Regeneron Scholar programs. Labs & Teams : Leads the Duong Lab at Montefiore Medical Center, focusing on translational research for clinical imaging solutions.
Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.
Professor Carlo Pappone is a Full Professor of Cardiology at Vita-Salute San Raffaele University (since 2019) and Director of the Arrhythmology Department at IRCCS Policlinico San Donato Hospital (since 2015). He has held previous academic/clinical leadership roles at IRCCS San Raffaele Hospital (2000-2010), Villa Maria Cecilia Hospital (2010-2015), and University of Naples Federico II (1990-2000). With 212 publications in top journals like NEJM, JAMA, and Circulation, he has made significant contributions to cardiac arrhythmia research. Current Positions Vita-Salute San Raffaele University (2019-present): Full Professor of Cardiology IRCCS Policlinico San Donato Hospital (2015-present): Director of Arrhythmology Department Previous Roles University of Naples Federico II (1990-2000) University of Michigan Ann Harbor (1990-2000) IRCCS San Raffaele Hospital (2000-2010) Villa Maria Cecilia Hospital (2010-2015) Research Focus: Specializing in cardiovascular diseases, his work spans atrial fibrillation ablation techniques, Brugada syndrome pathogenesis, heart failure device therapy, and ion channel disorders. His H-index of 53 and 18,407 citations reflect his substantial academic impact. Notable Scientific Contributions Author of 44 patents Principal Investigator in 14 clinical trials (clinicaltrials.gov) Developed circumferential pulmonary vein ablation technique Innovator in biventricular pacing systems for heart failure Pioneered research on non-excitatory current for cardiac contractility Scientific Recognition Awarded as Elite Reviewer of JACC (2005) Editorial Board Member of 6 leading journals Reviewer for NEJM, JAMA, Lancet, and Nature Medicine Education Medical Doctorate: University of Naples Federico II
Dr. Yayun Du is an Assistant Professor in the Department of Electrical and Computer Engineering at Vanderbilt University School of Engineering. She holds a Ph.D. in Robotics and System Control (Minor: Solid Mechanics) from UCLA (2022) and was a postdoctoral scholar at Northwestern University's Rogers Group through 2024. Current faculty at Vanderbilt University Ph.D. from University of California, Los Angeles Postdoctoral experience at Northwestern University Her research integrates bioelectronics and robotics through three core directions: 1) Developing multimodal wearable/implantable sensors for health monitoring, 2) Creating human-in-the-loop interaction systems using brain-computer interfaces, and 3) Applying machine learning to medical environment robotics. She has deployed four sensor types across seven hospitals globally, serving users from neonates to elderly patients. Dr. Du's recent publications focus on wireless bioelectronic devices ( PNAS ), sustainable sensor materials ( ACS Sustainable Chemistry & Engineering ), and agricultural robotics ( ICRA , IROS ). She serves as Associate Editor for ICRA 2025 and has received two Best Paper Award final nominations at IROS 2021. Finalist - Best Paper Award in Agri-Robotics (IROS 2021) Finalist - Best Paper Award in Robot Mechanisms and Design (IROS 2021) As head of the Du Group, she leads interdisciplinary research with applications in both healthcare and agricultural contexts, collaborating with Vanderbilt Institute for Surgery and Engineering (VISE) and clinical partners. Her work emphasizes deployable systems that transition from academic research to real-world implementation in medical and industrial environments.
Shu Yang is an Associate Professor of Statistics at North Carolina State University (NC State), specializing in causal inference, missing data analysis, and biostatistics. She holds a Ph.D. in Applied Mathematics and Statistics from Iowa State University and has held roles including Postdoctoral Fellow at Harvard University and Assistant Professor at NC State. Her research focuses on developing statistical methods for observational and clinical studies, particularly in healthcare and environmental applications. Education: Ph.D. in Applied Mathematics and Statistics from Iowa State University (2014) B.Sc. in Mathematics and Applied Mathematics from Beijing Normal University (2009) Research Interests: Dr. Yang’s work addresses challenges in causal inference, including longitudinal data analysis, missing data imputation, and high-dimensional statistics. She applies these methods to environmental health, cardiovascular diseases, HIV infection, and cancer research. Her team also explores spatial statistics and data integration techniques. Awards: 2025: Think, Collaborate & Do Ideation Award 2024: COPSS Emerging Leader Award, Cavell Brownie Mentoring Award 2022: University Faculty Scholar 2018: Ralph E. Powe Junior Faculty Enhancement Award Grants & Advising: She leads funded projects on causal inference methods in environmental health, sepsis detection, and marine protected areas. She advises over 20 Ph.D. students and postdocs, focusing on causal methods, data integration, and healthcare analytics.
Jeremy Dahl is a Professor of Radiology (Pediatric Radiology) at Stanford University School of Medicine. He directs the Ultrasound Imaging & Instrumentation Lab and serves as Director of Research Academic Affairs in the Department of Radiology since 2020. He holds multiple affiliations across Stanford including Bio-X, the Cardiovascular Institute, Wu Tsai Human Performance Alliance, Maternal & Child Health Research Institute, Stanford Cancer Institute, and Wu Tsai Neurosciences Institute. Dr. Dahl received his B.S. in Electrical Engineering from the University of Cincinnati (1999) and Ph.D. in Biomedical Engineering from Duke University (2004). His research focuses on developing ultrasonic beamforming and image reconstruction methods for diagnostic imaging applications, particularly techniques that generate high-quality images in difficult-to-image patients. His laboratory specializes in B-mode and Doppler imaging techniques that utilize additional information from ultrasonic wavefields to improve image quality and develop real-time imaging systems for clinical applications including cardiac, liver, and fetal imaging. Dr. Dahl's research has led to significant advancements in ultrasound molecular imaging platforms, sound speed estimation, aberration correction, and reverberation noise suppression. His work often bridges engineering innovation with clinical applications for cancer detection and other diseases. His recent publications demonstrate strong focus on machine learning applications in ultrasound, distributed aberration correction, and molecular imaging techniques. Fellow, American Institute of Ultrasound in Medicine (2021) Senior Member, Institute of Electrical and Electronics Engineers (2020) Distinguished Investigator Award, The Academy for Radiology & Biomedical Imaging Research (2018) Outstanding Paper Award, IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society (2011) Dr. Dahl serves in editorial roles for major journals including IEEE Transactions on Medical Imaging (2017-2024) and IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control (2013-Present). His laboratory has successfully translated numerous innovations into clinical applications, with multiple patents including recent developments in pulsed focused ultrasound therapy and speed of sound quantification.
Nabil Alshurafa is an Associate Professor at Northwestern University, holding joint appointments in the McCormick School of Engineering (Computer Science and Electrical and Computer Engineering) and the Feinberg School of Medicine (Preventive Medicine). He directs the HABits Lab, which focuses on developing mHealth systems to address health behaviors such as overeating, stress, and UV exposure. His work integrates wearable sensors, machine learning, and behavioral science to create passive sensing solutions. Education: PhD in Computer Science and Wireless Health (UCLA), MS and BS in Computer Science (UCLA). Research Interests: Body sensor networks, activity recognition, embedded systems, and health informatics. His lab designs wearable devices (e.g., neck-worn sensors, UV patches) and AI frameworks to detect behaviors like eating patterns and stress levels. Collaborations include domain experts in medicine and engineering to translate technical innovations into clinical interventions. Recent Projects: Developing systems for stress monitoring via ECG-PPG patches, UV exposure tracking, and just-in-time interventions for overeating. The lab emphasizes ethical design, privacy preservation, and user-centered technology. Students and Lab Team: Supervises PhD, MS, and undergraduate researchers in areas like machine learning, embedded systems, and health data analytics. Notable advisees include Rawan Alharbi (PhD candidate), Shibo Zhang (PhD student), and Wilson Wang (MS student). Labs/Teams: HABits Lab collaborates with experts in Preventive Medicine, Psychiatry, and Dermatology to advance interdisciplinary health research. Current projects include predictive analytics for weight loss and interventions targeting maternal stress during pregnancy.
Craig H. Meyer is a Professor in Biomedical Engineering and Radiology & Medical Imaging at the University of Virginia. He holds a Ph.D. from Stanford University and leads the Rapid MRI Research Group, focusing on developing advanced MRI techniques for cardiovascular disease, neural disorders, and pediatrics. His work integrates physics, signal processing, and machine learning to improve MRI acquisition and processing speed. Education: Ph.D. in Biomedical Engineering, Stanford University. Research Interests: Medical and Molecular Imaging, Signal and Image Processing, Biomedical Data Sciences, Biomechanics, and Cardiovascular Engineering. His innovations include fast spiral imaging, conjugate phase reconstruction, and machine learning-enhanced MRI denoising. Awards: Notably includes the Dean’s Award for Excellence in Team Science (2014), Fellowships from NAI (2021), AIMBE (2015), and ISMRM (2013). He also authored two landmark MRI papers recognized as pivotal in the field. Teaching: Courses include BME 6310 (Computation and Modeling in Biomedical Engineering) and BME 8782 (Magnetic Resonance Imaging). He emphasizes translational research, with applications in clinical MRI advancements and collaborative interdisciplinary projects. Labs/Groups: Rapid MRI Research Group focuses on cutting-edge MRI technologies, including real-time cardiac imaging and artifact reduction through deep learning.
Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.
Massimo Mischi is a Full Professor at the Faculty of Electrical Engineering of the Eindhoven University of Technology (TU/e) and chairs the Signal Processing Systems (SPS) Division , the largest division at TU/e with over 250 researchers. He founded the Biomedical Diagnostics (BM/d) Lab in 2012, which now includes 180 researchers and clinical/industrial advisors, focusing on biomedical signal processing for diagnostics and monitoring.
Dr. Hongtu Zhu is the Kenan Distinguished Professor of Biostatistics, Statistics, Radiology, Computer Science, and Genetics at the University of North Carolina at Chapel Hill (UNC). He holds affiliations with the Gillings School of Global Public Health and leads the Biostatistics and Imaging Genomics Analysis Lab. His expertise spans statistical learning, medical imaging, AI, and big data integration, with a focus on precision medicine and biomedicine. Dr. Zhu earned his PhD in Statistics from The Chinese University of Hong Kong (2000) and has held prior roles including DiDi Fellow/Chief Scientist (2018-2020) and Bao-Shan Jing Endowed Professor at MD Anderson Cancer Center (2016-2018). He has published over 345 peer-reviewed articles in top-tier journals like Nature, Science, and JASA, and actively contributes to editorial roles including Coordinating Editor of JASA. His research interests include neuroimaging analysis, knowledge graphs, and AI applications in healthcare. Notable awards include the COPSS Snedecor Award (2025), IEEE Fellowship (2025), and IMS Medallion (2027). He has mentored over 80 PhD students/postdoctoral fellows and serves on NIH grant review panels and professional organizations like the ASA's Section on Statistics in Imaging. Key Contributions: Imaging genomics, brain connectivity studies, ridesharing market optimization, medical AI frameworks Lab Innovations: Brain Imaging Genetics Knowledge Portal, Biomedical Knowledge Graph Interface Teaching: Advanced biostatistics courses (Generalized Linear Models, Deep Learning in Biomedicine) Recent work explores causal inference in healthcare, X chromosome's role in neurobiology, and AI ethics in medical vision-language models. His interdisciplinary projects bridge statistics, computer science, and clinical practice to address complex biomedical challenges.
Dr. Peter J.F. Lucas is a Full Professor specializing in Datamanagement & Biometrics with over 35 years of experience in artificial intelligence, probabilistic graphical models, and clinical decision support systems. His research spans intelligent systems, machine learning, and eHealth, with a focus on applying Bayesian networks and probabilistic logic to medical and non-medical domains.
Masoud Asgharian is a Professor in the Department of Mathematics and Statistics at McGill University. His research focuses on survival analysis, changepoint problems, nonparametric Bayesian methods, and data envelopment analysis. He has contributed to influential studies on dementia survival rates, censored data methodologies, and statistical efficiency measures. His work bridges biostatistics and operations research, with applications in public health and medical sciences. Key contributions include methodologies for prevalent cohort survival analysis, input relaxation efficiency measures in stochastic DEA, and causal inference techniques. Asgharian has collaborated extensively with researchers in epidemiology and biomedical engineering, as evidenced by his co-authored publications on topics ranging from tooth enamel properties to low-precision neural network quantization. His research has been published in high-impact journals such as New England Journal of Medicine , Journal of the American Statistical Association , and Biometrics . Current affiliations include leadership roles in statistical research at McGill, with ongoing projects in computational statistics and healthcare analytics.
Dr Nga Wun (Doris) Li is a Senior Lecturer at the University of Technology Sydney (UTS) within the Faculty of Design, Architecture and Building, Department of Fashion and Textiles. She leads research in seamless knitting technology, smart textiles, and sustainable fashion innovation. PhD in Fashion & Textile Design (HK PolyU, 2021) BA (Hons) in Fashion & Textiles (HK PolyU, 2012) Certifications in Wholegarment Machine (Shima Seiki, Japan) and Higher Education Pedagogy (UTS) Her research focuses on functional garments, knitting technology, and bio-informed textile design. Key projects include smart socks for DVT prevention , one-size sports bras , and buoyant swimwear for children . She combines knitting with machine learning and 3D printing for material innovation. Recent publications highlight her work on compression textiles (2025), wearable glucose sensors (2025), and knitted metasurfaces for acoustic comfort (2024). She has secured AU$52,000+ in grants across 5 funded projects. Fashion Design Award (Jeanswest, China) Outstanding Presentation & Research Paper Awards (2024) Dr Li supervises PhD and MPhil students in smart textiles and sustainable design while coordinating machine knitting courses. She collaborates with AiDLab (Hong Kong) and Powerhouse Museum (Australia).
Ruth Keogh is a Professor of Biostatistics and Epidemiology at the London School of Hygiene & Tropical Medicine (LSHTM), affiliated with the Medical Statistics Department within the Faculty of Epidemiology and Population Health. She is Co-Director of the Centre for Data and Statistical Science for Health (DASH) and serves as Departmental Research Degrees Coordinator. Her academic career has spanned roles from Lecturer (2012–2015) to Associate Professor (2015–2019) before attaining her current rank in 2019. Keogh holds advanced degrees including a DPhil in Medical Statistics/Epidemiology (University of Oxford, 2007), MSc in Applied Statistics (Oxford, 2003), and BSc in Mathematics and Statistics (University of Edinburgh, 2002). Her research focuses on causal inference, clinical trial emulation using real-world data, and applications in cystic fibrosis, infectious diseases, and public health. She leads projects on lung function trajectories, vaccine efficacy, and healthcare policy analysis. Her work integrates biostatistical methods with epidemiological studies, emphasizing rigorous analysis of observational data to inform clinical decisions. Notable areas include evaluating antibiotic treatments for cystic fibrosis patients, assessing diagnostic test accuracy for dengue and leptospirosis, and modeling vaccine effectiveness during the COVID-19 pandemic. She teaches courses in survival analysis, electronic health records, and health data science at LSHTM. Keogh has held leadership roles in the International Biometric Society and the STRATOS Initiative, and she has delivered keynote addresses at international conferences on trial emulation and biostatistical methods. Her contributions bridge methodological innovation and practical health challenges, with over 190 publications and active engagement in global health research networks.
